DK1299095T3 - Klart vandigt anæstetisk præparat - Google Patents
Klart vandigt anæstetisk præparatInfo
- Publication number
- DK1299095T3 DK1299095T3 DK00991825T DK00991825T DK1299095T3 DK 1299095 T3 DK1299095 T3 DK 1299095T3 DK 00991825 T DK00991825 T DK 00991825T DK 00991825 T DK00991825 T DK 00991825T DK 1299095 T3 DK1299095 T3 DK 1299095T3
- Authority
- DK
- Denmark
- Prior art keywords
- clear aqueous
- anesthetic preparation
- aqueous anesthetic
- preparation
- clear
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/40—Cyclodextrins; Derivatives thereof
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Nanotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Medical Informatics (AREA)
- Anesthesiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN573MU2000 IN187686B (da) | 2000-06-21 | 2000-06-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1299095T3 true DK1299095T3 (da) | 2004-10-11 |
Family
ID=11097257
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK00991825T DK1299095T3 (da) | 2000-06-21 | 2000-12-14 | Klart vandigt anæstetisk præparat |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US7138387B2 (da) |
| EP (1) | EP1299095B1 (da) |
| JP (1) | JP4907833B2 (da) |
| KR (1) | KR100810066B1 (da) |
| CN (1) | CN1254237C (da) |
| AP (1) | AP2002002674A0 (da) |
| AT (1) | ATE267592T1 (da) |
| AU (2) | AU3597201A (da) |
| BG (1) | BG107463A (da) |
| BR (1) | BR0017268A (da) |
| CA (1) | CA2414064C (da) |
| DE (1) | DE60011149T2 (da) |
| DK (1) | DK1299095T3 (da) |
| EA (1) | EA005589B1 (da) |
| ES (1) | ES2222271T3 (da) |
| HU (1) | HUP0301646A3 (da) |
| IL (1) | IL153387A0 (da) |
| IN (1) | IN187686B (da) |
| MX (1) | MXPA02012611A (da) |
| NO (1) | NO20025999D0 (da) |
| NZ (1) | NZ523643A (da) |
| PL (1) | PL359624A1 (da) |
| PT (1) | PT1299095E (da) |
| WO (1) | WO2001097796A1 (da) |
| YU (1) | YU2703A (da) |
| ZA (1) | ZA200300336B (da) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IN188917B (da) * | 2000-12-07 | 2002-11-23 | Bharat Surums & Vaccines Ltd | |
| US7034013B2 (en) | 2001-03-20 | 2006-04-25 | Cydex, Inc. | Formulations containing propofol and a sulfoalkyl ether cyclodextrin |
| NZ533536A (en) * | 2001-12-28 | 2006-11-30 | Mgi Gp Inc | Aqueous based pharmaceutical formulations of water-soluble prodrugs of propofol such as O-phosphonooxymethyl propofol |
| US20050239746A1 (en) * | 2002-02-01 | 2005-10-27 | Penkler Lawrence J | Pharmaceutical composition |
| US7550155B2 (en) | 2002-07-29 | 2009-06-23 | Transform Pharmaceuticals Inc. | Aqueous pharmaceutical compositions of 2,6-diisopropylphenol (propofol) and their uses |
| PL375874A1 (en) * | 2002-07-29 | 2005-12-12 | Transform Pharmaceuticals, Inc. | Aqueous 2,6-diisopropylphenol pharmaceutical compositions |
| SI1585548T1 (sl) * | 2002-12-09 | 2018-11-30 | Abraxis Bioscience, Llc | Sestave in metode odmerjanja farmakoloških sredstev |
| EP1704858A4 (en) * | 2004-01-14 | 2008-06-04 | Otsuka Pharma Co Ltd | PROPOFOL-CONTAINING FAT-EMULSION PREPARATION |
| CN101090736A (zh) * | 2004-09-13 | 2007-12-19 | 印度血清及疫苗有限公司 | 具抗微生物的防腐效果的用于静脉给药的稳定乳剂组合物 |
| JP2009504634A (ja) * | 2005-08-12 | 2009-02-05 | ブハラット セルムズ アンド ヴァクシンズ リミテッド | プロポフォールを含む水性麻酔剤組成物 |
| WO2007128866A2 (en) * | 2006-05-09 | 2007-11-15 | Novobion Oy | Novel chemical compositions |
| EP2712900A1 (en) * | 2008-03-11 | 2014-04-02 | 3M Innovative Properties Company | Phototools having a protective layer |
| WO2010148288A2 (en) * | 2009-06-19 | 2010-12-23 | Lyotropic Therapeutics, Inc. | Pharmaceutical formulations with low aqueous levels of free unbound drug |
| EP2456823A4 (en) | 2009-07-21 | 2012-12-26 | 3M Innovative Properties Co | CURABLE COMPOSITION, METHOD FOR COATING A PHOTO TOOL, AND COATED PHOTO TOOL |
| KR101781659B1 (ko) | 2009-09-16 | 2017-09-25 | 쓰리엠 이노베이티브 프로퍼티즈 컴파니 | 플루오르화된 코팅 및 그로 제조된 포토툴 |
| EP2478034A1 (en) | 2009-09-16 | 2012-07-25 | 3M Innovative Properties Company | Fluorinated coating and phototools made therewith |
| US8268067B2 (en) * | 2009-10-06 | 2012-09-18 | 3M Innovative Properties Company | Perfluoropolyether coating composition for hard surfaces |
| EP2345427A1 (de) * | 2010-01-14 | 2011-07-20 | SapioTec GmbH | Flurankomplex |
| EP2484350B1 (de) * | 2011-02-04 | 2016-04-20 | Roewer, Norbert, Univ.-Prof. Dr. med. | Pharmazeutische Zubereitung, enthaltend einen Komplex eines Propofolsalzes mit einem Cyclodextrin |
| AU2013273764B2 (en) * | 2011-11-29 | 2016-05-05 | Zoetis Services Llc | Pharmaceutical compositions |
| EP3446692A1 (en) | 2011-11-29 | 2019-02-27 | Jurox Pty. Ltd. | Methods of preserving injectable pharmaceutical compositions comprising a cyclodextrin and a hydrophobic drug |
| CN103263404B (zh) * | 2012-04-28 | 2017-12-01 | 中国人民解放军军事医学科学院放射与辐射医学研究所 | 一种复合麻醉药物 |
| US10646439B2 (en) * | 2016-01-29 | 2020-05-12 | Cuda Anesthetics, Llc | Aqueous pharmaceutical formulation comprising propofol |
| FR3117337B1 (fr) | 2020-12-10 | 2023-04-28 | Centre Hospitalier Univ De Lille | Composition pharmaceutique contenant du propofol, une cyclodextrine ou un dérivé de cyclodextrine et un sel pharmaceuticalement acceptable |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA962214B (en) * | 1995-04-10 | 1996-10-07 | Farmarc Nederland Bv | Pharmaceutical composition |
-
2000
- 2000-06-21 IN IN573MU2000 patent/IN187686B/en unknown
- 2000-12-14 AU AU3597201A patent/AU3597201A/xx active Pending
- 2000-12-14 WO PCT/IN2000/000124 patent/WO2001097796A1/en active IP Right Grant
- 2000-12-14 PL PL00359624A patent/PL359624A1/xx unknown
- 2000-12-14 DK DK00991825T patent/DK1299095T3/da active
- 2000-12-14 ES ES00991825T patent/ES2222271T3/es not_active Expired - Lifetime
- 2000-12-14 HU HU0301646A patent/HUP0301646A3/hu unknown
- 2000-12-14 NZ NZ523643A patent/NZ523643A/en not_active IP Right Cessation
- 2000-12-14 AT AT00991825T patent/ATE267592T1/de active
- 2000-12-14 PT PT00991825T patent/PT1299095E/pt unknown
- 2000-12-14 CA CA2414064A patent/CA2414064C/en not_active Expired - Fee Related
- 2000-12-14 YU YU2703A patent/YU2703A/sh unknown
- 2000-12-14 CN CNB008198292A patent/CN1254237C/zh not_active Expired - Fee Related
- 2000-12-14 DE DE60011149T patent/DE60011149T2/de not_active Expired - Lifetime
- 2000-12-14 AU AU2001235972A patent/AU2001235972B2/en not_active Ceased
- 2000-12-14 AP APAP/P/2002/002674A patent/AP2002002674A0/en unknown
- 2000-12-14 EP EP00991825A patent/EP1299095B1/en not_active Expired - Lifetime
- 2000-12-14 EA EA200300047A patent/EA005589B1/ru not_active IP Right Cessation
- 2000-12-14 JP JP2002503273A patent/JP4907833B2/ja not_active Expired - Fee Related
- 2000-12-14 KR KR1020027017362A patent/KR100810066B1/ko not_active IP Right Cessation
- 2000-12-14 IL IL15338700A patent/IL153387A0/xx not_active IP Right Cessation
- 2000-12-14 US US10/296,765 patent/US7138387B2/en not_active Expired - Lifetime
- 2000-12-14 BR BR0017268-5A patent/BR0017268A/pt not_active Application Discontinuation
- 2000-12-14 MX MXPA02012611A patent/MXPA02012611A/es active IP Right Grant
-
2002
- 2002-12-13 NO NO20025999A patent/NO20025999D0/no not_active Application Discontinuation
-
2003
- 2003-01-13 ZA ZA200300336A patent/ZA200300336B/en unknown
- 2003-01-16 BG BG107463A patent/BG107463A/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1299095T3 (da) | Klart vandigt anæstetisk præparat | |
| DK1857105T3 (da) | Kathartisk præparat | |
| NO20031483L (no) | Vaksine | |
| NL1017075A1 (nl) | Preparaat. | |
| DE50104135D1 (de) | Wässrige zusammensetzungen | |
| NO20024172L (no) | Vaksine | |
| DE60124662T8 (de) | Karosseriestruktur | |
| IS6686A (is) | Hýdrógel-drifið lyfjaskömmtunarform | |
| DZ3409A1 (fr) | Association therapeuthique | |
| DK1199054T3 (da) | Væskefrakturhånddel | |
| NO20026175L (no) | Vaksinesammensetning | |
| DE60133295D1 (de) | Sulphoniumsalz-verbindung | |
| FI20002644A (fi) | Liitäntäalusta | |
| NO20023367L (no) | Glyburide-preparat | |
| EE05197B1 (et) | Linesoliid - kristallivorm II | |
| DE60116202D1 (de) | Perkutan absorbierende Zubereitung | |
| DE60103683D1 (de) | Wässrige Pestizidzusammensetzung | |
| DE60032946D1 (de) | Katheter | |
| ATE450652T1 (de) | Wässrige zusammensetzung | |
| DK1389116T3 (da) | Kathartisk præparat | |
| BR0113783B1 (pt) | Composição aquosa | |
| NO20032957D0 (no) | Farmasöytisk emulsjonspreparat | |
| FR2817889B1 (fr) | Coffrage | |
| DE60107973D1 (de) | Gewebehandlungszubereitung | |
| DK1267974T3 (da) | Inhalationsapparat |